CalciMedica (CALC) Competitors $2.94 -0.50 (-14.53%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$2.94 +0.00 (+0.17%) As of 08/1/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CALC vs. CRGX, DMAC, NLTX, FDMT, GALT, EPRX, GNFT, IPHA, LYEL, and VTYXShould you be buying CalciMedica stock or one of its competitors? The main competitors of CalciMedica include CARGO Therapeutics (CRGX), DiaMedica Therapeutics (DMAC), Neoleukin Therapeutics (NLTX), 4D Molecular Therapeutics (FDMT), Galectin Therapeutics (GALT), Eupraxia Pharmaceuticals (EPRX), GENFIT (GNFT), Innate Pharma (IPHA), Lyell Immunopharma (LYEL), and Ventyx Biosciences (VTYX). These companies are all part of the "pharmaceutical products" industry. CalciMedica vs. Its Competitors CARGO Therapeutics DiaMedica Therapeutics Neoleukin Therapeutics 4D Molecular Therapeutics Galectin Therapeutics Eupraxia Pharmaceuticals GENFIT Innate Pharma Lyell Immunopharma Ventyx Biosciences CalciMedica (NASDAQ:CALC) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends. Is CALC or CRGX more profitable? CARGO Therapeutics' return on equity of -45.93% beat CalciMedica's return on equity.Company Net Margins Return on Equity Return on Assets CalciMedicaN/A -171.81% -100.43% CARGO Therapeutics N/A -45.93%-39.58% Which has higher earnings and valuation, CALC or CRGX? CalciMedica is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCalciMedicaN/AN/A-$13.70M-$1.56-1.88CARGO TherapeuticsN/AN/A-$167.50M-$4.62-0.97 Do analysts rate CALC or CRGX? CalciMedica presently has a consensus price target of $16.00, indicating a potential upside of 444.22%. CARGO Therapeutics has a consensus price target of $15.40, indicating a potential upside of 242.98%. Given CalciMedica's stronger consensus rating and higher probable upside, equities research analysts plainly believe CalciMedica is more favorable than CARGO Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CalciMedica 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00CARGO Therapeutics 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86 Does the media favor CALC or CRGX? In the previous week, CalciMedica and CalciMedica both had 2 articles in the media. CARGO Therapeutics' average media sentiment score of 1.08 beat CalciMedica's score of 0.00 indicating that CARGO Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment CalciMedica Neutral CARGO Therapeutics Positive Which has more volatility and risk, CALC or CRGX? CalciMedica has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500. Comparatively, CARGO Therapeutics has a beta of 0.28, suggesting that its share price is 72% less volatile than the S&P 500. Do institutionals and insiders hold more shares of CALC or CRGX? 93.2% of CARGO Therapeutics shares are owned by institutional investors. 41.6% of CalciMedica shares are owned by insiders. Comparatively, 2.9% of CARGO Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryCalciMedica beats CARGO Therapeutics on 7 of the 12 factors compared between the two stocks. Get CalciMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for CALC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CALC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CALC vs. The Competition Export to ExcelMetricCalciMedicaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$48.06M$3.00B$5.49B$9.52BDividend YieldN/A2.43%4.73%4.09%P/E Ratio-1.8817.6228.7523.81Price / SalesN/A179.21372.2066.02Price / CashN/A41.9535.4557.96Price / Book2.758.508.275.55Net Income-$13.70M-$55.06M$3.25B$259.20M7 Day Performance-22.63%-3.99%-3.72%-4.64%1 Month Performance86.08%9.58%4.30%4.41%1 Year Performance-34.81%6.70%25.87%17.95% CalciMedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CALCCalciMedica2.9898 of 5 stars$2.94-14.5%$16.00+444.2%-34.4%$48.06MN/A-1.8830CRGXCARGO Therapeutics2.3075 of 5 stars$4.50-0.1%$15.40+242.6%-73.1%$207.26MN/A-0.97116DMACDiaMedica Therapeutics1.7417 of 5 stars$4.75-6.1%$10.75+126.2%+19.4%$204.75MN/A-7.4620News CoverageUpcoming EarningsGap UpNLTXNeoleukin TherapeuticsN/A$21.68-4.6%N/A-46.3%$203.75MN/A-6.9790FDMT4D Molecular Therapeutics2.5461 of 5 stars$4.39-5.4%$29.56+573.1%-62.7%$203.46M$23K-1.38120News CoverageUpcoming EarningsAnalyst ForecastGap UpGALTGalectin Therapeutics2.5387 of 5 stars$3.18+3.9%$6.00+88.7%+63.3%$202.21MN/A-4.449Positive NewsEPRXEupraxia Pharmaceuticals2.5642 of 5 stars$5.61-1.0%$11.00+96.0%+85.5%$201.76MN/A-7.3829Upcoming EarningsGNFTGENFIT1.7154 of 5 stars$4.01-3.6%$13.00+224.2%-8.9%$200.50M$76.77M0.00120News CoverageIPHAInnate Pharma2.352 of 5 stars$2.14-2.7%$11.00+414.0%-1.4%$197.27M$12.62M0.00220Gap UpLYELLyell Immunopharma3.0247 of 5 stars$13.37-2.6%$15.00+12.2%-63.3%$194.75M$60K-0.53270Upcoming EarningsGap DownVTYXVentyx Biosciences2.9124 of 5 stars$2.72-10.7%$10.00+268.3%+17.4%$194.34MN/A-1.5630News CoverageShort Interest ↑ Related Companies and Tools Related Companies CARGO Therapeutics Alternatives DiaMedica Therapeutics Alternatives Neoleukin Therapeutics Alternatives 4D Molecular Therapeutics Alternatives Galectin Therapeutics Alternatives Eupraxia Pharmaceuticals Alternatives GENFIT Alternatives Innate Pharma Alternatives Lyell Immunopharma Alternatives Ventyx Biosciences Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CALC) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CALC Stock Alerts